Completed
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
NCT00153933
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Center Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Center Boston, Massachusetts, United States